A study of 25 years of data from Danish women aged 15-59 suggests that meningiomas (tumours of the meninges) may be a very rare side effect of contraceptives containing a progestogen. The Danish Medicines Agency is therefore raising a safety signal in the European Pharmacovigilance Risk Assessment Committee (PRAC).